美國的髖關節置換市場預測

本報告提供美國的髖關節置換市場相關調查分析，提供各市場區隔的主要市場資料(收益，數量，平均價格，企業佔有率，流通佔有率）資料，加上主要企業簡介等，為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 美國的髖關節置換市場

• 收益(實際成果)
• 收益(預測)
• 數量(實際成果)
• 數量(預測)
• 平均價格
• 流通佔有率:各收益
• 企業佔有率:各收益

第4章 美國的髖關節置換設備市場上主要企業概要

• DePuy Companies
• Stryker Corporation
• Zimmer Holdings, Inc.
• Biomet, Inc.
• Smith & Nephew Plc
• Wright Medical Group, Inc.

第5章 髖關節置換市場開發中產品

第6章 財務交易形勢

• 資產交易
• 債權發行
• 非上市股票(PE)
• 創業融資

第7章 最近的趨勢

• 企業宣傳
• 決算發表
• 政府·公共產業
• 法律規章
• 其他的重要的趨勢
• 產品新聞
• 策略和產業計畫

第8章 附錄

圖表

GlobalData's new report, "United States Hip Reconstruction Market Outlook to 2021", provides key market data on the United States Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size for Hip Reconstruction market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.
• Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
• 2014 company shares and distribution shares data for Hip Reconstruction market.
• Global corporate-level profiles of key companies operating within the United States Hip Reconstruction market.
• Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

• Develop business strategies by identifying the key market segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

• 1.1. List of Tables
• 1.2. List of Figures

2. Introduction

• 2.1. What Is This Report About?
• 2.2. Hip Reconstruction Market Segmentation
• 2.3. Definitions of Markets Covered in the Report

3. Hip Reconstruction Market, United States

• 3.1. Hip Reconstruction Market, United States, Revenue ($m), 2007-2014
• 3.2. Hip Reconstruction Market, United States, Revenue ($m), 2014-2021
  • 3.2.1. Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
  • 3.2.2. Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
  • 3.2.3. Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.2.4. Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
• 3.3. Hip Reconstruction Market, United States, Volume (Units), 2007-2014
• 3.4. Hip Reconstruction Market, United States, Volume (Units), 2014-2021
  • 3.4.1. Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014
  • 3.4.2. Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2007-2014
  • 3.4.3. Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.4.4. Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2014-2021
• 3.5. Hip Reconstruction Market, United States, Average Price ($), 2007-2021
• 3.6. Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2013-2014
• 3.7. Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Hip Reconstruction Market

• 4.1. DePuy Companies
  • 4.1.1. Company Overview
• 4.2. Stryker Corporation
  • 4.2.1. Company Overview
• 4.3. Zimmer Biomet Holdings, Inc.
  • 4.3.1. Company Overview
• 4.4. Biomet, Inc. (Inactive)
  • 4.4.1. Company Overview
• 4.5. Smith & Nephew Plc
  • 4.5.1. Company Overview
• 4.6. MicroPort Scientific Corporation
  • 4.6.1. Company Overview
• 4.7. DJO Finance LLC
  • 4.7.1. Company Overview

5. Hip Reconstruction Market Pipeline Products

6. Financial Deals Landscape

• 6.1. Debt Offerings
  • 6.1.1. Zimmer Raises USD500 Million in Public Offering of 1.45% Notes Due 2017
  • 6.1.2. Zimmer Raises USD1.15 Billion in Public Offering of 2% Notes Due 2018
  • 6.1.3. Zimmer Raises USD1.5 Billion in Public Offering of 2.7% Notes Due 2020
  • 6.1.4. Zimmer Raises USD750 Million in Public Offering of 3.15% Notes Due 2022
  • 6.1.5. Zimmer Raises USD2 Billion in Public Offering of 3.55% Notes Due 2025
  • 6.1.6. Zimmer Raises USD500 Million in Public Offering of 4.25% Notes Due 2035
  • 6.1.7. Zimmer Raises USD1.25 Billion in Public Offering of 4.45% Notes Due 2045
  • 6.1.8. Wright Medical Raises USD633 Million in Private Placement of 2% Notes Due 2020
• 6.2. Partnerships
  • 6.2.1. DePuy Synthes Enters into Agreement with Radlink
• 6.3. Venture Financing
  • 6.3.1. OrthAlign Raises USD15 Million in Venture Financing

7. Appendix

• 7.1. Research Methodology
  • 7.1.1. Coverage
  • 7.1.2. Secondary Research
  • 7.1.3. Primary Research
  • 7.1.4. Market Modeling and Forecasting
  • 7.1.5. Company Share Analysis
  • 7.1.6. Distribution Share Analysis
• 7.2. Expert Panel
• 7.3. GlobalData Consulting
• 7.4. Contact Us
• 7.5. Disclaimer

List of Tables

• Table 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Table 2: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Table 3: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Table 4: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Table 5: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Table 6: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Table 7: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
• Table 8: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
• Table 9: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
• Table 10: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
• Table 11: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
• Table 12: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
• Table 13: Hip Reconstruction Market, United States, Average Price ($), Historic, 2007-2014
• Table 14: Hip Reconstruction Market, United States, Average Price ($), Forecast, 2014-2021
• Table 15: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
• Table 16: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2014
• Table 17: Hip Reconstruction Market Pipeline Products
• Table 18: Zimmer Raises USD500 Million in Public Offering of 1.45% Notes Due 2017
• Table 19: Zimmer Raises USD1.15 Billion in Public Offering of 2% Notes Due 2018
• Table 20: Zimmer Raises USD1.5 Billion in Public Offering of 2.7% Notes Due 2020
• Table 21: Zimmer Raises USD750 Million in Public Offering of 3.15% Notes Due 2022
• Table 22: Zimmer Raises USD2 Billion in Public Offering of 3.55% Notes Due 2025
• Table 23: Zimmer Raises USD500 Million in Public Offering of 4.25% Notes Due 2035
• Table 24: Zimmer Raises USD1.25 Billion in Public Offering of 4.45% Notes Due 2045
• Table 25: Wright Medical Raises USD633 Million in Private Placement of 2% Notes Due 2020
• Table 26: DePuy Synthes Enters into Agreement with Radlink
• Table 27: OrthAlign Raises USD15 Million in Venture Financing
• Table 28: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

• Figure 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Figure 2: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Figure 3: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Figure 4: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
• Figure 5: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Figure 6: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
• Figure 7: Hip Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
• Figure 8: Hip Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
• Figure 9: Partial Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
• Figure 10: Primary Hip Replacement Market, United States, Volume (Units), Historic, 2007-2014
• Figure 11: Partial Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
• Figure 12: Primary Hip Replacement Market, United States, Volume (Units), Forecast, 2014-2021
• Figure 13: Hip Reconstruction Market, United States, Company Share (%) 2014
• Figure 14: GlobalData Epidemiology-Based Forecasting Model
• Figure 15: GlobalData Capital Equipment-Based Forecasting Model
• Figure 16: Primary Interviews by Participant Type (%)